In breast cancer, TNFR2 protects malignant cells from DNA damage via the AKT signaling pathway (48) and induces NF-κB via p42/p44 mitogen-activated protein kinase (MAPK) to accelerate tumor cell growth (49). The gene discussed is NFKB1; the disease is neoplasm.